Shanghai Allist Pharmaceuticals Co. Ltd. Class ASSE: 688578

Announcement on Voluntary Disclosure of Obtaining Notice of Drug Clinical Trial Approval for New Indications of Furmonertinib

· Issued by Shanghai Allist Pharmaceuticals Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Obtaining Notice of Drug Clinical Trial Approval for New Indications of Furmonertinib

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis